When injectable alternative (incretin) to insulin for treatment of T2DM were in sight a few months back, we had undertaken a project of an anonymous questionnaire survey of patients with T2DM seen in our practice taking insulin. This evidence concerns the gene INS and type 2 diabetes mellitus.